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PURPOSE. Simian virus (SV)40–immortalized human corneal ep-
ithelial (HCE-T) cells have been widely used as an in vitro
model of human corneal epithelial cells. The nature of this cell
line was assessed for genomic aberrations and cellular hetero-
geneity.
METHODS. For the quantitative measurement of genomic aber-
rations, array-based comparative genomic hybridization (CGH)
analysis was performed. For identification of cellular heteroge-
neity, cell morphology, growth kinetics, transepithelial electri-
cal resistance, and transfection/transcriptional efficiency were
analyzed. Real-time PCR and chromosomal fluorescent in situ
hybridization (cFISH) against some gained or lost loci were
performed, to assess genomic heterogeneity. Expressed se-
quence tags (ESTs) for this cell line were collected to assess
differences in the gene expression profiles between HCE-T
cells and normal corneal epithelial cells. Southern blot analysis
and inverse PCR analyses were used to determine the genomic
integration site of the SV40 large T antigen gene (LTAG).
RESULTS. Array CGH analysis demonstrated that the genomic
content of HCE-T cells is different from the normal healthy
genome. The results from cellular functional assays, real-time
PCR, and cFISH strongly indicated that HCE-T cells consist of a
significant number of heterogeneous cell populations. The
genomic integration site of the SV40 large T antigen was at
p22.1 of chromosome 9.
CONCLUSIONS. The results indicate that HCE-T cells have an
altered genomic content and that they are composed of heter-
ogeneous cell populations. This should be considered when
conducting experiments or interpreting the results of studies
that use this cell line. (Invest Ophthalmol Vis Sci. 2009;50:
604–613) DOI:10.1167/iovs.08-2239
Simian virus (SV)40–immortalized human corneal epithelial(HCE-T) cells were established in 1995 by Araki-Sasaki et
al.1 to be used as an in vitro model for human corneal epithelial
cells. Although several types of cell line currently exist for this
specific epithelial cell type,2–7 the HCE-T cell line appeared to
be the one most favored and frequently used, possibly because
it is free of infectious virus particles and is easy to maintain.
The HCE-T cell line has historically been used for a range of
studies, most of which are involved in drug development,8,9
elucidation of cellular signaling pathways,10,11 or molecular
interactions maintaining homeostasis of normal corneal epithe-
lial cells.
Immortalization of the HCE-T cells was performed by ad-
enoviral introduction of the large T antigen gene (LTAG),
originally encoded within the SV40 viral genome.12 Its transla-
tion product functions as a viral oncoprotein binding to p53
(TP53) and retinoblastoma (RB)-1 proteins via respective bind-
ing domains, thereby inhibiting their functions in a variety of
animal cells.13 Since both of these proteins have strong antitu-
mor activity,14–16 cells expressing this oncoprotein have an
inclination toward oncogenic transformation. This raises the
possibility for the generation of rare cells that can survive
crisis15 and ultimately yields an infinite replicative lifespan.
Genomic aberrations, including various types of mutations
or numerical/structural chromosomal aberrations, primarily oc-
cur during cell division or when cells are exposed to various
types of mutagens. In normal somatic cells, the cell cycle of
those possessing an aberrant genome is stopped or the cell is
or removed via various types of cell cycle check-point mecha-
nisms17 to avoid tumor evolution. Since TP53 and RB1 play a
central role in such error-correcting mechanisms,18,19 cells
lacking these genes may accumulate abnormal genomic con-
tents with each cell division. In fact, most of the naturally
occurring cancers and immortalized cell lines have been found
to lose one or both of these proteins14,20 and to have disor-
dered genomic contents, as measured by karyotypic analysis21
or, much more intimately, by classic or array-based compara-
tive genomic hybridization (CGH) analysis.22 Therefore, after
extensive passages, HCE-T cells may have an altered genomic
content, as reported in other SV40-immortalized cell lines.23,24
In addition, HCE-T cells may be composed of numerous heter-
ogenous cell populations, since such genomic aberrations may
randomly occur and may be variable among individual cells. So,
although HCE-T cells were reported to be derived from a single
clone and were well-characterized from the biochemical points
of view when they were initially established, that situation may
not be the case now. This study was performed to gain better
understanding of the current status of HCE-T cells in view of
genomic aberrations and cellular heterogeneity.
MATERIALS AND METHODS
Cell Culture
After the absence of mycoplasma contamination was confirmed, HCE-T
cells (passage number: 62) were cultured in DMEM/F12 medium sup-
plemented with 10% FBS, 10 ng/mL EGF, 5 g/mL insulin, 0.1 g/mL
cholera toxin, and penicillin/streptomycin in an incubator supplied
with 95% air and 5% CO2 at 37°C, according to a previous report.
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Array CGH
Genomic DNA was extracted from 1  106 HCE-T cells (DNAeasy
blood and tissue kit; Qiagen, Tokyo, Japan). Genomic DNA from a
normal human female (Promega, Madison, WI) was used as a normal
control. These DNAs were labeled respectively with Cy5 and Cy3
fluorophores, purified, mixed together, and hybridized against a 244-k
microarray for array CGH (Agilent Technologies, Palo Alto, CA), which
spans the entire human genome at a median resolution of 7.4 or 16.5
kb for coding and noncoding regions, respectively. Hybridized fluores-
cence signals were captured and analyzed (CGH Analytics software;
Agilent Technologies, Palo Alto, CA).
Subcloning of the HCE-T Cells
Subcloning of the HCE-T cells was performed by the limited-dilution
method. In brief, trypsin-dissociated HCE-T cells were transferred to
wells of a 96-multiwell plate at an average cell density of 0.5 cells per
well. Only subclones, which were confirmed to be of a single colony,
were subcultured for subsequent experiments.
Scanning Electron Microscopy (SEM)
Cells were cultured on coverslips (Thermanox; Agar Scientific, Stan-
sted, UK). Five days after the cells reached confluence, they were fixed
by immersion of the coverslips in 2.5% phosphate-buffered glutaralde-
hyde (pH 7.4) for 60 minutes, postfixed in 1% osmium tetroxide for 20
minutes, washed in distilled water, contrasted in 0.5% uranyl acetate,
and dehydrated in ethanol. The cells were dried at room temperature
after infiltration with hexamethyldisilazane (HMDS). The coverslips
were mounted on aluminum stubs with carbon cement (Leit-C; Plano
GmbH, Wetzlar, Germany), gold-coated in a sputtercoater (EMscope
COOE; Emitech, Ashford, UK), and examined by scanning electron
microscope (Philips XL20; FEI Co., Eindhoven, The Netherlands).
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FIGURE 1. Results of array CGH analysis. (A) The value of log-transformed relative hybridization signals for probes within 2 Mb of the genomic region
was averaged and scatterplotted against the whole human genome longitudinally from the short arm of chromosome 1 to the long arm of chromosome
X. Since the HCE-T cells were transformed from corneal epithelial cells derived from a female, no data for the Y chromosome are demonstrated. Regions
that were determined to be aberrant by the ADM-2 algorithm are indicated in red (top) or green (bottom), indicating gain or loss, respectively. The array
CGH data have been deposited in the NCBI Gene-Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/projects/geo/ National Center for Biotech-
nology Information), and are freely accessible under accession number GSM278477. (B–E) Local CGH data for four selected gene loci. An oncogenic gene
locus (BIRC3) was gained (B) and a tumor-suppressor gene locus (WRN) was lost (C). The TP53 (D) and KRT12 (E) gene loci remained unchanged.
TABLE 1. Summarized List of All Primers Used in the Study
Primer Name Sequence
Real-time PCR
Luc-F GTACACCTTCGTGACTTCCCATTT
Luc-R TTTTGTCCCGGTCGAAGCT
PPM1L-F TCTATGGCTAAAAAACAATAACCA
PPM1L-R GAGGGCTGCAATCTGTTTTG
PCDH10-F GTTGACATAAAAGTAAAAGGCAAGC
PCDH10-R CATTATTGTTTCAGTATTCCATGTG
CSMD1-F TCGGGGGCTAGAGATACACATGC
CSMD1-R AGAGAACACAGCCGACAGAATAAC
AMOTL1-F GTGGATATATTTGCTTACATTCCG
AMOTL1-R TCTTGTATCAGCCCCCAAAG
FDX1-F AGACCAAGCCCTTTTGCTAAG
FDX1-R TTTCTTTCGTTTCCGCCTC
MCF2-F ACATGGACACAAGCTTGCAG
MCF2-R ATGCATTTTGAAGGTCCTGC
CREB5-F TCTACTTAGAGAATGATTCCCATCC
CREB5-R CATGAAATACGCTTAGCCTGC
Southern Blot
Probe1-F ACATGTAAGCGACGGATGTG
Probe1-R CCCCCTGAACCTGAAACATA
Probe2-F GGCGGGTGACGTAGTAGTGT
Probe2-R GCGAAAATGGCCAAATCTTA
Inverse PCR
Mbo-1-F CGTAATATTTGTCTAGGGCCGCGGGGACTTTG
Mbo-1-R AACATCCGCCTAAAACCGCGCGAAAATTG
Mbo-2-F GACTTTGACCGTTTACGTGGAGACTCGCCC
Mbo-2-R CTGTGTACACCGGCGCACACCAAAAAC
Mbo-3-F GGTGTTTTTCTCAGGTGTTTTCCGCGTTCC
Mbo-3-R TTGCCACATCCGTCGCTTACATGTGTTCC
Pst-common-F CACTGCGTTCCAGGCAATGCTTTAAATAATC
Pst-1-R GCCTAAAACCGCGCGAAAATTGTCACTTC
Pst-2-R ACCAAAAACGTCACTTTTGCCACATCCGTC
Pst-3-R AACCGCGCGAAAATTGTCACTTCC
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Growth Kinetics Determined by
Population-Doubling (PD) Analysis
Each of the HCE-T subclones was seeded at 2 104 to 1 105 in a T25
plastic flask. The next day, cells that failed to reattach were collected
and counted. The attached cells were fed every other day and har-
vested at 3 to 5 days, while their growth was still in a mid-log phase,
a time at which cell confluence is roughly less than 70%. Then, the
harvested subclones were repeatedly passaged using the same proce-
dure as described earlier. The increment of PD per passage was
calculated with the formula log2 [Ch/(Cs  Cf)], where Ch corresponds
to the number of harvested cells, Cs to the number of seeded cells, and
Cf to the number of cells that failed to reattach.
Transepithelial Electrical Resistance (TER)
Subcloned HCE-T cells were seeded at 8  104 cells on a porous
membrane (0.4-m Transwell; Corning, Inc., Corning, NY) and were
grown to form a confluent monolayer. TER was monitored daily for 21
days using an epithelial voltohmmeter (EVOM; World Precision Instru-
ments, Inc., New Haven, CT). The measured TER was subtracted from
the background TER, determined on a blank membrane, and further
normalized by the area of the monolayer as transepithelial electrical
resistivity (in ohms per square centimeter). The number of replicates
for each subclone was five.
Transfection and Transcription Efficiency
A plasmid vector harboring a firefly luciferase gene (pGL4.13[luc2/
SV40] Vector; Promega) or a modified GFP gene (pmaxGFP; Amaxa-
biosystems, Cologne, Germany) was introduced into each of the sub-
cloned HCE cells (Lipofectamine LTX; Invitrogen Corp., Carlsbad, CA).
After a 24-hour incubation, the cells were lysed and respectively
subjected to a luciferase assay (Dual-Luciferase Reporter Assay System;
Promega) or fluorometric analysis (VersaFluo; Bio-Rad Laboratories,
Inc., Hercules, CA), along with a chemiluminescence cell-titer assay
(Celltiter-Glo; Promega). Data from both reporter assays were normal-
ized with data from the cell-titer assay. The introduced luciferase
vector DNA was also quantitated by real-time PCR to monitor its
transfection efficiency. All experiments were performed in triplicate.
Quantitation of Locus Copy Number by
Real-Time PCR
The copy number of some gained or lost genomic loci was quantitated
by real-time PCR (Prism 7000 Sequence Detection System; Applied
TABLE 2. List of Highly Altered Loci in HCE-T Cells
No. of
Region*
Cytogenic
Band Oncogenes† Tumor-Suppressor Genes‡
Corneal Epithelial
Cell–Specific Genes§
Gain
1 3q13.2-q13.31
2 5q14.1-q35.3 ACSL6, AFF4, APC,
ARHGAP26, CSF1R, FLT4,
NPM1, NSD1, PDGFRA, TLX3
APC, CTNNA1, MCC CXCL14, HSPA9, TGFB1,
TRIM36
3 6p12.3
4 6q25.2-q27 FGFR10P, MAS1, MLLT4
5 8q21.11-q24.3 COX6C, MYC, RUNX1T1 EXT1, RECQL4 FABP5, RPL8
6 9q22.31–q22.32 FANCC, PTCH
7 11p13-q23.1 BIRC3, CCND1, DDX10, FGF3,
FGF4, LMO2, MAML2,
NUMA1, PICALM, POU2AF1
ATM, DDB2, EXT2, MEN1, PPP2R1B,
SDHD, WT1
AK026607, EIF3M, GSTP1,
FTH1, PRDX5, TIMM8B
8 12p13.33-q12 ERC1, ETV6, KRAS, ZNF384 MLF2
9 14q21.1-q24.2 GPHN, RAD51L1
10 16p12.1-q24.3 CBFA2T3, CBFB, FUS CDH1, CYLD, FANCA MT1X, NQO1
11 19p13.2-p12 BRD4, CRTC1, ELL, LYL1, TPM4 CDKN2D
12 20q11.21-q13.2 GNAS, TOP1 LPIN3
13 Xp22.31-p21.3
Loss
1 3q23-q29 BCL6, EIF4A2, EVI1, GMPS,
LPP, MDS1, MLF1, TFRC
2 4p16.3-q31.1 AFF1, CHIC2, FGFR3, FIP1L1,
KIT, PDGFRA, RAP1GDS1,
RHOH, TEC
3 7q21.13-q31.1
4 8p23.3-q11.21 MYST3, PCM1, WHSCIL1 WRN CLU
5 9q21.13-q21.33
6 9q22.33-q33.2 CEP1, TAL2 XPA KIAA0368
7 10p14-p11.21 MLLT10
8 11q23.1-q25 ARHGEF12, CBL, FLI1, MLL,
ZBTB16
APLP2, TMPRSS4
9 13q11-q12.13 ZNF198 GJB2
10 14q11.1-q11.2 CCNB1IP1, GOLGA5, TRA@
11 18p11.22-p11.21
12 Xq23-q28 MCF2, SEPT6 GPC3
* Number of aberrant regions correspond to those in Figure 1.
† Listed oncogenes are cited in Futreal et al.27
‡ The listed tumor-suppressor genes were obtained from a publicly accessible Web book (Cancer Medicine, Table 7-1; http://www.ncbi.nlm.
nih.gov/books/bv.fcgi?ridcmed6.table.1598; National Center for Biotechnology Information, Bethesda, MD).
§ Listed genes are specifically expressed in in vivo corneal epithelial cells.
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Biosystems [ABI] Japan, Ltd., Tokyo, Japan) using genomic DNA from
the subcloned HCE-T cells in a fluorescence-containing PCR buffer
(SYBR Green Master Mix; ABI Japan, Ltd.). Primer pairs were designed
against the selected genomic loci (Table 1, and see Fig. 6) by referring to
the Uni-STS database (http://www.ncbi.nlm.nih.gov/sites/entrez?db
unists/ provided in the public domain by the National Center for
Biotechnology Information, Bethesda, MD). Before analysis, each
primer pair was confirmed to produce a specific amplified product. All
experiments were performed in duplicate.
Chromosomal Fluorescent In Situ
Hybridization (cFISH)
The copy number of a genomic locus was further assessed by cFISH. In
brief, each subclone was cultured and the cell cycle stopped at meta-
phase with 20 ng/mL of colcemide for 2 hours, swollen in a hypotonic
buffer (0.05 M KCl), fixed with Carnoy’s fixative, and dropped onto a
silanated glass slide to make a metaphase spread. A BAC plasmid
(RP11-506N24), covering a genomic region close to the FDX1 gene
locus (11q22.3), was restriction-digested with Sau3AI, random-labeled
with 16-biotin dUTP, and its repetitive sequences were masked with
Cot-1 DNA. The metaphase spread of each of the HCE-T subclones was
denatured, hybridized with the biotin-labeled probe, washed, incu-
bated with streptavidin-HRP, developed with fluorescence-labeled
(Alexa488) tyramide (Invitrogen Corp.), counterstained with DAPI,
and photographed with a laser-confocal fluorescence microscope (TCS
SP2 AOBS; Leica Microsystems, Co., Ltd., Wetzlar, Germany).
Genomic Southern Blot Analysis
The integration site of the SV40-LTAG in the genome of subcloned
HCE-T cells was analyzed by genomic Southern blot analysis. In brief,
a partial sequence of the left arm of the adenoviral vector (Probe 1, see
Fig. 8A) was PCR-amplified, gel-purified, and 32P-labeled with a random
labeling kit (Rediprime II DNA Labeling System; GE Healthcare UK Ltd.,
Buckinghamshire, UK). Genomic DNA, extracted from each of the
subcloned HCE-T cells, was restriction-digested with PstI, electropho-
resed on a 0.7% agarose gel, and transferred to a nylon membrane. The
blotted nylon membrane was hybridized with the RI-labeled probe,
washed, autoradiographed against a radio-sensitive imaging plate (BAS-
MS2025; Fuji Film, Tokyo, Japan), and scanned with an image analyzer
(BAS5000; Fuji Film).
Inverse PCR
The integration site of SV40-LTAG was further determined by inverse
PCR. In brief, genomic DNA (HCE-T-15) was digested with PstI or
MboI, self-ligated, and PCR-amplified with a pair of primers, both
directing outward from the left arm of the adenoviral vector. The
amplified products were electrophoresed, gel purified, and sequenced
(BigDye 3.1; ABI Japan, Ltd.). The obtained sequence data was then
scanned for the entire human genome (Blat software; http://genome.
brc.mcw.edu/cgi-bin/ provided in the public domain byUCSC Genome
Browser, University of California at Santa Cruz, Santa Cruz, CA).
EST Analysis
Ranked RNA expression in the HCE-T cells was analyzed as described
elsewhere.26 In brief, double-stranded cDNA was synthesized with a
pUC119-based vector primer, digested with MboI and BamHI restric-
tion enzymes to obtain the same 5 overhang at both ends, self-ligated,
and transformed into JM-109-competent Escherichia coli cells
(Toyobo, Tokyo, Japan). After overnight incubation, the colonies were
picked, isothermally amplified (Templiphi; GE Healthcare), and se-
quenced. The obtained sequence data was then trimmed, repeat-
masked, and scanned against human transcript databases.
Statistical Analysis
Statistical analysis was performed on a computer with commercially
available statistics software (SAS ver 9.1, SAS Institute Inc., Cary, NC).
For growth kinetics, TER, and gene transfer and transcription effi-
ciency, one-factor analysis of variance (ANOVA), was performed to test
whether the average values for these experiments were identical
among subclones.
RESULTS
Genomic Aberration in HCE-T Cells
Array CGH data indicated that the HCE-T cells manifested an
aberrant genomic content compared with the normal human
genome; some genomic regions were gained while others
were lost (Fig. 1A). Significantly gained regions were found in
chromosomes 3, 5, 6, 8, 9, 11, 12, 14, 16, 19, 20, and X, while
significantly lost regions were found in chromosomes 3, 4, 7, 8,
9, 10, 11, 13, 14, 18, and X (Table 2). In some chromosomes,
some regions were gained, whereas others remained un-
changed or were lost. Thus, the genomic aberrations do not
simply correspond to numerical chromosomal abnormalities
(aneuploidy or polyploidy) but point to the existence of more
complicated situations such as aneuploidy combined with
chromosomal fusion, reciprocal or nonreciprocal transloca-
tion, locus amplification or deletion, or double minute chro-
mosome. As listed in Table 2, some oncogenes were gained
and some tumor-suppressor genes were lost, indicating that
such alterations may individually or cooperatively contribute to
the enhancement of the growth activity of HCE-T cells. Con-
versely, some tumor-suppressor genes were gained and some
oncogenes were lost, implying that not all these alterations are
related to the oncogenic transformation of this cell line. It is
possible that most of the observed genomic aberrations reflect
the accumulations of randomly occurring alterations without
any impact on oncogenic transformation.
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FIGURE 2. Morphology of subcloned HCE-T cells. Shown are sub-
cloned HCE-T cells 2 weeks after they reached confluence (A, HCE-T-2;
B, -3; C, -6; D, -13; E, -15; F, -17; G, -20; H, -21; and I, -22). Note the
marked difference in the appearance of the cell-to-cell borders. (J–L)
SEM of subcloned HCE-T cells showing that HCE-T-2 (J) and -6 (K) cells
were in close contact with cells and exhibited tightly apposed cell
borders. On the other hand, individual HCE-T-15 cells (L) were clearly
separate and their cell borders easily identifiable. Scale bar, 50 m.
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Cell Morphology
A limited-dilution method was used to obtain nine subclones
(HCE-T-2, -3, -6, -13, -15, -17, -20, -21, and -22) as monoclonal,
growth-competent cell populations. During their growth (con-
fluence  90%), their cellular shapes were almost identical.
However, after the subclones reached confluence, they ac-
quired their proper cell shape. As shown in Figures 2A–I,
subclones HCE-T-13, 15, 20, and 22 had clearly distinguishable
cell-to-cell borders; cell-to-cell borders in the other subclones
were far more difficult to distinguish. SEM data were consistent
with this observation, as subclone HCE-T-15 exhibited easily
identifiable cell borders compared with subclones HCE-T-2 and
-6 whose cells appeared tightly apposed, thus obscuring indi-
vidual cell borders (Figs. 2J–L).
Growth Kinetics
The growth kinetics of the subcloned HCE-T cells was sub-
jected to PD analysis. As shown in Figure 3, there was a slight,
yet significant variation in growth rate among the subclones
(P 5.2 10–6 (ANOVA, Fig. 3, inset). The maximum growth
rate was found in the HCE-T-17 cells, whereas the minimum
growth rate occurred in the HCE-T-6 cells. The difference
between these two subclones was approximately 7.9 PDs at 32
cumulative days, indicating that at day 32, HCE-T-17 cells ex-
ceeded HCE-T-6 cells by approximately 240-fold (27.9).
Transepithelial Electrical Resistance
Because there were significant differences among the sub-
clones in the appearance of the cell-to-cell borders, we exam-
ined the epithelial barrier function by measuring TER. As
shown in Figure 4, TER varied significantly among the nine
subclones, with P  0.01 at all measurements (ANOVA). Of
note, the subclones with clearly distinguishable cell-to-cell bor-
ders (HCE-T-13, -15, -20, and -22) had an inclination toward a
rapid initial increase and higher TER than did other subclones
exhibiting hardly distinguishable cell-to-cell borders (HCE-T-2,
-3, -6, -17 and -21).
Transfection and Transcription Efficiency
Transgene efficiency can vary greatly among different types of
cells. This was also the case among the subcloned HCE-T cells
in our study (Fig. 5A), and although the variance among the
subclones was relatively small, it was statistically significant
(ANOVA, P  0.01). However, the transcriptional activity ob-
tained with the luciferase (Fig. 5B) or the GFP (Fig. 5C) re-
porter genes demonstrated a larger amount of variation among
the subcloned HCE-T cells, and that variation was statistically
significant (ANOVA, P 2.9 1014 and 3.7 1013, respec-
tively). It is noteworthy that the transcriptional activity of these
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FIGURE 3. Cell growth kinetics in each subclone. Growth kinetics was
quantitatively measured as population doubling (PD) at each passage.
Cumulative PD was plotted against cumulative days. Inset: The PD
values over passages were averaged for each subclone. *Statistical
significance as judged by the Scheffe´ test at a risk rate of 5%.
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each of the subcloned HCE-T cells.
Each of the subloned cells was
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two reporter genes did not coincide with each other. Since
these reporter genes are regulated under different promoters,
it is probable that the composition of the transcriptional fac-
tors is different in each of the subclones and that the observed
differences among the subclones may be attributable to this
heterogeneity.
Heterogeneity in the Locus Copy Number among
the HCE-T Subclones
Since the observed heterogeneous cellular features may be at
least partially attributable to genomic heterogeneity, we quan-
titated the copy number of some selected genomic loci with
real-time PCR against the subcloned HCE-T cells (Fig. 6). Of the
six analyzed loci (three for gained and three for lost loci), five
were found to be variable among the HCE-T subclones, and
that variability was statistically significant (ANOVA, 1.1 
103, 2.2  107, 4.6  103, and 2.1  105 for FDX1,
MCF2, PPML1, and PCDH10, respectively). To validate the
results of real-time PCR, cFISH was performed against a FDX1
gene locus (Fig. 7). The copy number of the FDX1 gene locus
in each of the HCE-T subclones was almost identical with, but
slightly smaller than that estimated by real-time PCR, possibly
because in the cFISH analysis, we recognized two closely
residing signals as a twin signal due to a sister chromatid
formation and thus counted it as one copy, while in real-time
PCR analysis, such cases should theoretically correspond to
two copies.
Integration of SV40-LTAG
To confirm that all the subcloned HCE-T cells derived from a
unique single cell, we performed genomic Southern blot anal-
ysis. PstI digestion of genomic DNA from all HCE-T subclones
produced a single band of approximately 1.6 kb (Fig. 8B), thus
providing evidence that all the subclones were descended
from a single cell. Inverse PCR analysis disclosed that the
integration site of SV40-LTAG was 9p22.1 (Fig. 8E), between
bases 18,699,829 and 18,699,830 (base numbers assigned by
the UCSC Genome Bioinformatics Group; Mar. 2006 Assembly;
http://genome.ucsc.edu/index.html University of California at
Santa Cruz). Of interest, this region was close to a known
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FIGURE 5. Transfection and transcription efficiency. Transfection (A) and transcriptional efficiency for luciferase (B) and GFP vector (C) were
assessed for each of the HCE-T subclones. Each experiment was performed in triplicate. The variations in the data of these three experiments were
statistically significant (ANOVA, P  0.01, 2.9  1014 and 3.7  1013, respectively). Although the variation in transfection efficiency was
relatively small, the transcriptional efficiency of both vectors varied to a greater degree among the HCE-T subclones. Presence of statistical
significance was evaluated by the Scheffe´ test as listed in Supplementary Table S2, http://www.iovs.org/cgi/content/full/50/2/604/DC1.
FIGURE 6. Quantitation of locus copy number by real-time PCR. Genomic aberrations in each of the subcloned HCE-T cells were quantitatively
measured by real-time PCR. Primer pairs were selected from the established database of sequence-tagged sites for genomic loci with confirmed gain
(A, AMOTL1, 11q14.3; B, FDX1, 11q22; C, MCF2, Xq27) or loss (D, PPM1L, 3q26.1; E, PCDH10, 4q28.3; F, CSMD1, 8p23.2) in HCE-T cells as
determined by array CGH analysis. All data were first normalized with data from an unchanged locus (CREB5, 7p15.1) and further normalized so
that the copy number of the normal genome (N) was 2. All experiments were performed in duplicate. The presence of statistical significance was
evaluated by the Scheffe´ test as listed in Supplementary Table S2, http://www.iovs.org/cgi/content/full/50/2/604/DC1.
IOVS, February 2009, Vol. 50, No. 2 Genomic Aberrations and Heterogeneity in HCE-T Cells 609
fragile site FRA9G (9p22.2),28 suggesting the possible relation-
ship between genomic fragility and the SV40-LTAG integration
as previously reported.29
EST Analysis
Next, we identified genes dominantly expressed in the HCE-T
cells. We identified 740 genes as dominant transcripts in 1135
sequenced clones derived from 1728 selected colonies. As
shown in Table 3, most of the dominantly transcribed genes
were ribosomal protein subunits, suggesting that protein syn-
thesis may be accelerated in this cell line. Unexpectedly, this
profile is quite distinct from that of in vivo corneal epithelial
cells.33 Most of the corneal epithelial-specific genes, such as
keratin 12 (KRT12),33,34 KRT3, or aldehyde dehydrogenase 3
(ALDH3A1),35 were not identified in the current analysis al-
though KRT3 and ALDH enzyme activity was immunohisto-
chemically or biochemically confirmed in the initial study.1 We
posit that these genes are transcriptionally repressed in the
current batch of this cell line, possibly because these genes are
not indispensable for the maintenance of this cell line.
DISCUSSION
Our array CGH analysis indicated that the genomic content of
HCE-T cells was altered. Our study also documented that
HCE-T cells were composed of heterogeneous cell popula-
tions. Considering the nature of SV40-LTAG, our results may be
attributable, at least partially, to the fact that HCE-T cells lack
functional TP53 and RB1 proteins, which play critical roles in
repairing or removing cells with an anomalous genome. There-
fore, although HCE-T cells may initially harbor a normal healthy
genome, their genomic content may have been gradually al-
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graphs below the images) obtained
from at least 20 metaphase chromo-
some spreads. Two closely aligned
signals were judged as a twin signal
due to sister chromatid formation
and thus were counted as one copy
in this analysis.
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tered by each cell division and might currently still be in the
process of changing.
Naturally occurring cancers have been reported to manifest
genomic aberration profiles that reflect their original cell
types.22 Neoplasms evolved from keratinocytes, such as esoph-
ageal36,37 or cervical squamous cell carcinoma,38–40 are char-
acterized by the amplification of 3q, 5p, and 8q. We found that
of these, 3q and 8q were also amplified in HCE-T cells, sug-
gesting that these genomic regions are important even for
SV40-LTAG-induced immortalization of keratinocyte-type cells.
The gain of oncogenes and the loss of tumor-suppressor
genes represent crucial events during the stepwise process of
oncogenic transformation. In this study, of particular interest
was that c-myc, a major proto-oncogene41,42 that activates
transcription of the hTERT gene,43 is significantly amplified.
The hTERT gene is a rate-limiting factor for telomerase,44–46 a
prerequisite holoenzyme for naturally occurring carcinogene-
sis47–49 and artificial immortalization50,51 of eukaryotic cells in
bypassing the second bottleneck for immortalization (M215).
Moreover, TP53 and RB1, two major tumor-suppressor genes,
deserve attention because they are inhibited by SV40-LTAG and
are lost or mutated in various kinds of cancers.52,53 We found
that their genomic loci, p13.1 on chromosome 17 and region
14.2 on chromosome 13, long arm, respectively, remained
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FIGURE 8. Genomic integration of the SV40-LTAG. (A) Schematic representation of the restriction enzyme map of the left arm of the adenoviral
vector harboring SV40-LTAG. Empty boxes: SV40-LTAG open reading frame; bold lines: its intronic and flanking sequences derived from the SV40
viral genome. (B) Copy numbers and genomic integration of SV40-LTAG were determined by genomic Southern blot analysis using probe 1. All
subclones demonstrated an identical single band at approximately 1.6 kb. (C) To select the optimal restriction enzyme for inverse PCR analysis,
Southern blot analysis was performed with probe 2 against genomic DNA (HCE-T-15) digested with various restriction enzymes. MboI and PstI were
selected because they generated relatively shorter positive bands than other enzymes. (D) Successful PCR amplification was obtained with one
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unchanged in this cell line. Our results appear to be reason-
able, given that the SV40-LTAG suppresses functions of these
genes only at the protein level, not at the genomic level.
Besides aberrant genomic content, our current data reveal
that the gene expression profiles of the HCE-T cells were
markedly different from those of in vivo corneal epithelial cells.
Although it can be explained by several theoretical factors, a
previous report54 indicated that altered gene expression may
be attributable to altered genomic content. Therefore, most of
the genes whose copy numbers were confirmed to be in-
creased or decreased in our study may be differentially ex-
pressed between in vivo corneal epithelial cells and HCE-T
cells. Also, besides such a gene dosage aspect, epigenetic
alteration may play a large influence on altered gene expres-
sion and cellular features. For example, our preliminary data
indicated that the KRT12 gene, whose genomic locus
(17q21.2) was unchanged in the present study, is highly ex-
pressed in corneal epithelial cells in vivo,34 but is virtually
absent in the HCE-T cells, possibly due to its genomic methyl-
ation status (Kawasaki S, et al. IOVS 2007;48:ARVO E-Abstract
2724). Taken together, HCE-T cells appear to be considerably
different from in vivo corneal epithelial cells, possibly due to
various gene regulation mechanisms.
In summary, our current data demonstrate that the genomic
content of HCE-T cells is altered and that the cells are hetero-
geneous. Based on findings reported herein, we suggest that
investigators who are planning to use this cell line must first
consider whether it is appropriate for their study purposes.
Furthermore, our observations should alert researchers to the
fact that any results obtained from this cell line need to be
carefully interpreted. Last, it is probable that the HCE-T cells
maintained or deposited at various laboratories or cell banks
are not genetically identical, especially when they are subcul-
tured too many times. Therefore, and as is often said, research-
ers should use this cell line with a passage number as small as
possible. It is our hope that the findings in this report helps
contribute to the success of future studies employing the
HCE-T cell line.
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